2024 annual financial data
Aligos Therapeutics 2024 Net margin
Aligos Therapeutics 2024 net margin with verified reported values.
Direct answer
Net margin was -3,326.01%.
Operating income was -89,154,000 USD and net income was -131,211,000 USD.
Operating cash flow was -80,743,000 USD.
Get free Aligos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,945,000 USD
- Operating income
- -89,154,000 USD
- Net income
- -131,211,000 USD
- Operating cash flow
- -80,743,000 USD